Peritoneal and systemic inflammation: The benefits of using biocompatible peritoneal dialysis fluids

Peritoneal Dialysis International

Volumn 28, Issue 1, 2008, Pages 28-31

  Boulanger, Eric ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; BICARBONATE; C REACTIVE PROTEIN; CA 125 ANTIGEN; CD14 ANTIGEN; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; GLYOXAL; HLA DR ANTIGEN; HYALURONIC ACID; INTERLEUKIN 6; LACTIC ACID; METHYLGLYOXAL; PERITONEAL DIALYSIS FLUID; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; BIOMATERIAL; DIALYSIS FLUID;

APOPTOSIS; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CLINICAL TRIAL; DIALYSIS MEMBRANE; HUMAN; INFECTION RATE; INFLAMMATION; INTERMETHOD COMPARISON; KIDNEY FAILURE; MESOTHELIUM CELL; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; ANIMAL; DRUG EFFECT; PERITONEUM;

ANIMALS; BIOCOMPATIBLE MATERIALS; DIALYSIS SOLUTIONS; HUMANS; INFLAMMATION; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS;

EID: 42449118562     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800106     Document Type: Note

References (25)

1. Pajek J, Kveder R, Bren A, Gucek A, Ihan A, Osredkar J, et al. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int 2008; 28: 44-52.
2. Rougier JP, Moullier P, Piedagnel R, Ronco PM. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 1997; 51: 337-47.
3. Witowski J, Bender T, Wisniewska-Elnur J, Ksiazek K, Passlick-Deetjen J, Breborowicz A, et al. Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se. Perit Dial Int 2003; 23:381-90.
4. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, et al. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. J Am Soc Nephrol 1998; 9:2349-56.
5. Topley N, Kaur D, Petersen MM, Jorres A, Williams JD, Faict D, et al. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 1996; 7:218-24.
6. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992; 267:14987-97.
7. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108: 949-55.
8. Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004; 19:2208-16.
9. Boulanger E, Grossin N, Wautier MP, Taamma R, Wautier JL. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int 2007; 71:126-33.
10. Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002; 61: 148-56.
11. Mortier S, Faict D, Lameire N, De Vriese A. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005; 67:1559-65.
12. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 2003; 14:2109-18.
13. Jonasson P, Braide M. Acute in vivo toxicity of heat-sterilized glucose peritoneal dialysis fluids to rat peritoneal macrophages. Perit Dial Int 1998; 18:376-81.
14. Szeto C, Chow K, Lam C, Leung C, Kwan B, Chung K, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - a 1-year randomized control trial. Nephrol Dial Transplant 2007; 22:552-9.
15. Foley R, Murray A, Li S, Herzog C, McBean A, Eggers P. et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16:489-95.
16. Pecoits-Filho R, Lindholm B, Stenvinkel P. End-stage renal disease: a state of chronic inflammation and hyperleptinemia. Eur J Clin Invest 2003; 33:527-8.
17. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:1928-9.
18. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 1994; 91:11704-8.
19. Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hori O, Zoukourian C, et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A 1994; 91:7742-6.
20. Justo P, Sanz A, Egido J, Ortiz A. 3,4-dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005; 54:2424-9.
21. Liu BF, Miyata S, Hirota Y, Higo S, Miyazaki H, Fukunaga M, et al. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 2003; 63:947-57.
22. Schmitt C, von Heyl D, Rieger S, Arbeiter K, Bonzel K, Fischbach M, et al. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant 2007; 22:2038-44.
23. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004; 95:233-8.
24. Zheng Z, Sederholm F, Anderstam B, Qureshi A, Wang T, Södersten P, et al. Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats. Kidney Int 2001; 60:2392-8.
25. Zheng Z, Anderstam B, Qureshi A, Heimbürger O, Wang T, Södersten P, et al. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats. Kidney Int 2002; 62:1447-53.